Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/19419794

Download in:

View as

General Info

PMID
19419794